Community Oncology Alliance shared on LinkedIn:
“Bispecific therapies are a promising treatment option for patients with cancer, opening new doors and increasing the flexibility of treatment.
Join us on Thursday, November 19 at 4 p.m. ET for a discussion of the ways independent community oncology practices can sustainably create bispecific programs at their practice.
Moderator Christine Pfaff will be joined by Kyle Kitchen, Stacey Hield and Joshua Cox as they discuss how bispecific therapy programs, specifically ramp-up dosing programs, have been successfully implemented at their respective practices.
Christine Pfaff/LinkedIn
Kyle Kitchen, Stacey Hield and Joshua Cox/LinkedIn
They’ll discuss clinical protocols, multidisciplinary team coordination, and other factors key to running a successful program.”
Read more: Webinar: Delivering Bispecific Therapies in Community Oncology.
Other articles about bispecific therapies on OncoDaily.